↓ Skip to main content

TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015
Altmetric Badge

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
11 Mendeley